Brain SPECT in neurology and psychiatry

Journal of Nuclear Medicine

Volumn 42, Issue 4, 2001, Pages 611-623

  Camargo, E E ^a  

^a NONE   (Brazil)

Author keywords

99mTc hexamethylpropyleneamine oxime; 99mTc L,L ethyl cysteinate dimer; Brain SPECT; Neurologic diseases; Psychiatric disorders

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; EPIDEPRIDE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODINE 123; IOMAZENIL; LISURIDE; RADIOPHARMACEUTICAL AGENT;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN DISEASE; BRAIN TUMOR; CEREBROVASCULAR DISEASE; COMPULSION; DEMENTIA; DEPRESSION; DRUG ABUSE; DRUG UPTAKE; EPILEPSY; GILLES DE LA TOURETTE SYNDROME; HEAD INJURY; HUMAN; HUNTINGTON CHOREA; ISOTOPE LABELING; MENTAL DISEASE; NEUROLOGIC DISEASE; NEURORADIOLOGY; OBSESSION; PANIC; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN; BRAIN DISEASES; BRAIN INJURIES; CEREBROVASCULAR DISORDERS; DEMENTIA; EPILEPSY; HUMANS; MENTAL DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035048681     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Brain SPECT in clinical practice. Part 1. Perfusion
2. Test-retest results of HMPAO brain uptake
3. Visual stimulation increases technetium-99m-HMPAO distribution in human visual cortex
4. 99m-Tc-HMPAO SPECT imaging identifies cerebral activation changes during the Stroop test
5. Prolonged hypoperfusion and early stroke after transient ischemic attack
6. One-day protocol for cerebral perfusion reserve with acetazolamide
7. Brain SPECT with dipyridamole stress to evaluate cerebral flow reserve in carotid artery disease
8. 99mTc-HMPAO SPECT cerebral perfusion measurements during the first 48 hours for the localization of cerebral infarction
9. Discrepancies in brain perfusion SPECT findings between Tc-99m HMPAO and Tc-99m ECD: Evaluation using dynamic SPECT in patients with hyperemia
10. Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography
11. Evaluation of regional cerebral blood flow using single-photon emission computed tomography for the selection of patients for local fibrinolytic therapy of acute cerebral embolism
12. Predictive value of brain perfusion single-photon emission computed tomography in acute cerebral ischemia
13. rCBF-SPECT in brain infarction: When does it predict outcome?
14. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography
15. Cerebral infarction within six hours of onset: Prediction of completed infarction with technetium-99m-HMPAO SPECT
16. Simple visual analysis of brain perfusion on HMPAO SPECT predicts early outcome in acute stroke
17. Benzodiazepine receptors in chronic cerebrovascular disease: Comparison with blood flow and metabolism
18. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease: A comparison with PET study
19. Assessing adequacy of collateral circulation during balloon test occlusion of the internal carotid artery with technetium-99m HMPAO SPECT
20. HMPAO SPECT to assess neurologic deficits during balloon test occlusion
21. A single-photon emission computed tomography study of hypoperfusion after subarachnoid hemorrhage
22. Diagnosis of Alzheimer's disease: Report of an International Psychogeriatric Association Special Meeting Work Group under the co-sponsorship of Alzheimer's Disease International, the European Federation of Neurological Societies, the World Health Organization, and the World Psychiatric Association
23. Functional and structural brain imagings in dementia
24. SPECT in early- and late-onset Alzheimer's disease
25. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: A SPECT blood flow study
26. Quantitative changes in mesial temporal volume, regional cerebral blood flow and cognition in Alzheimer's disease
27. Cortical circumferential profile of SPECT cerebral perfusion in Alzheimer's disease
28. Toward a definite diagnosis of Alzheimer's disease
29. The scintigraphic appearance of Alzheimer's disease: A prospective study using technetium-99m-HMPAO SPECT
30. Neuroimaging of vessel amyloid in Alzheimer's disease
31. Synthesis and amyloid binding properties of rhenium complexes: Preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain
32. Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging
33. Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses
34. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease
35. Cerebral perfusion patterns in vascular dementia of Binswanger type compared with senile dementia of Alzheimer type: A SPECT study
36. Frontal lobe degeneration: Clinical, neuropsychological, and SPECT characteristics
37. 99mTc-HMPAO SPECT in the investigation of dementia?
38. 99mTc-HMPAO SPECT with CT and MRI studies
39. Cortical cerebral blood flow in HIV-1-related dementia complex
40. 99mTc)-HMPAO SPECT and cognitive impairment in Parkinson's disease: A comparison with dementia of the Alzheimer type
41. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients
42. 123I]beta-CIT SPECT
43. The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans
44. Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine
45. Autoimmune thyroiditis and a rapidly progressive dementia: Global hypoperfusion on SPECT scanning suggests a possible mechanism
46. SPECT brain imaging in epilepsy: A meta-analysis
47. Evaluation of technetium-99m-ECD in childhood epilepsy
48. 99mTc ethyl cysteinate dimer single photon emission computed tomography in patients with refractory partial epilepsy
49. Ipsilateral thalamic hypoperfusion on interictal SPECT in temporal lobe epilepsy
50. Increased contralateral cerebellar uptake of technetium-99m-HMPAO on ictal brain SPECT
51. Redistribution on I-123 IMP SPECT in children and adolescents with partial seizures
52. Preictal SPECT in temporal lobe epilepsy: Regional cerebral blood flow is increased prior to electroencephalography-seizure onset
53. Brain single-photon emission computed tomography imaging in Landau-Kleffner syndrome
54. 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy?
55. Presurgical identification of epileptic foci with iodine-123 iomazenil SPECT: Comparison with brain perfusion SPECT and FDG PET
56. Mapping the distribution of amobarbital sodium in the intracarotid Wada test by use of Tc-99m HMPAO with SPECT
57. An analysis of cerebral blood flow in acute closed-head injury using technetium-99m-HMPAO SPECT and computed tomography
58. Technetium-99m-HMPAO SPECT in the evaluation of patients with a remote history of traumatic brain injury: A comparison with x-ray computed tomography
59. Focal cerebral hyperemia after focal head injury in humans: A benign phenomenon?
60. SPECT brain perfusion imaging in mild traumatic brain injury without loss of consciousness and normal computed tomography
61. One-year follow-up of technetium-99m-HMPAO SPECT in mild head injury
62. Discrepancies between HMPAO and ECD SPECT imaging in brain tumors
63. Thallium-201 SPECT imaging of brain tumors: Methods and results
64. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: Association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy
65. Rapid differential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT
66. Thallium-201 brain SPECT of lymphoma in AIDS patients: Pitfalls and technique optimization
67. Imaging of brain tumors in AIDS patients by means of dual-isotope thallium-201 and technetium-99m sestamibi single-photon emission tomography
68. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine
69. Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance
70. Iodine-123-iodo-lisuride SPECT in Parkinson's disease
71. Iodine-123-epidepride-SPECT: Studies in Parkinson's disease, multiple system atrophy and Huntington's disease
72. 123I] β-CIT striatal uptake correlates with symptom severity in Parkinson's disease
73. 123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease
74. Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography
75. Technetium-99m HMPAO imaging in patients with basal ganglia disease
76. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease
77. Elevated frontal cerebral blood flow in obsessive-compulsive patients: A SPECT study
78. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients
79. A fluoxetine induced frontal lobe syndrome in an obsessive-compulsive patient
80. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest: Differential correlates with obsessive-compulsive and anxious-avoidant dimensions
81. Dopamine D2 receptor availability in patients with Gilles de la Tourette syndrome studied with SPECT
82. Regional cerebral blood flow imaging with SPECT in psychiatric disease: Focus on schizophrenia, anxiety disorders and substance abuse
83. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics
84. Regional brain function in hallucinations: A study of regional cerebral blood flow with 99m-Tc-HMPAO-SPECT in patients with auditory hallucinations, tactile hallucinations, and normal controls
85. Psychomotor slowing, negative symptoms and dopamine receptor availability: An IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients
86. 123I]-iodobenzamide SPECT study
87. Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort
88. 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment
89. Comparison of SPECT applications in neurology and psychiatry
90. Regional cerebral blood flow in patients with refractory unipolar depression measured with Tc-99m HMPAO SPECT
91. Functional brain imaging in the evaluation of psychiatric illness
92. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique
93. 99mTc-hexamethylpropyleneamine oxime SPECT in elderly depressed patients
94. Hypofrontality and negative symptoms in major depressive disorder
95. Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT
96. Brain perfusion is abnormal in cocaine-dependent polydrug users: A study using technetium-99m-HMPAO and ASPECT
97. Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users
98. Neuropsychiatric effects of cocaine: SPECT measurements